What Is Feline Inflammatory Bowel Disease?
Inflammatory Bowel Disease (IBD) refers to a group of conditions characterized bychronic inflammatory cell infiltration of the gastrointestinal mucosal layer. According to the WSAVA International Gastrointestinal Standardization Group, diagnosing IBD requires ruling out other known causes of intestinal inflammation (such as parasites, bacterial infections, food allergies, etc.). IBD is one of the most common causes of chronic vomiting and diarrhea in cats, typically affecting middle-aged to older cats (average age at diagnosis: 6-8 years). The most common histological type islymphocytic-plasmacytic enteritis.
Clinical Symptoms
Symptoms vary depending on which part of the gastrointestinal tract is affected. According to a review in the Journal of Feline Medicine and Surgery (Jergens, 2012):
| Affected Area | Primary Symptoms |
|---|---|
| Stomach | Chronic vomiting (most common); vomitus may contain bile or food |
| Small intestine | Chronic diarrhea (watery or soft stool), weight loss, appetite changes, protein-losing enteropathy |
| Large intestine | Increased frequency of defecation, mucus or blood in stool, tenesmus |
Other common manifestations include:
- Intermittent symptoms: Alternating good and bad periods, with possible remission for weeks before relapse
- Appetite changes: May increase or decrease
- Abdominal discomfort: Discomfort response when the abdomen is palpated
- Thickened intestinal walls: May be palpable in severe cases
- Unkempt coat: Due to poor nutrient absorption
Diagnostic Process
According to WSAVA's gastrointestinal disease diagnostic guidelines, IBD is adiagnosis of exclusion, requiring the following steps:
- Baseline blood work and urinalysis: Rule out metabolic diseases (hyperthyroidism, kidney disease, etc.)
- Fecal examination: Rule out parasitic infections (including Giardia)
- FeLV/FIV testing: Rule out viral causes
- Serum cobalamin (B12) and folate: Assess small intestinal absorption; low B12 suggests ileal disease
- Abdominal ultrasound: Evaluate intestinal wall thickness and layer structure, check lymph node size
- Dietary elimination trial: Before invasive procedures, attempt to rule out food intolerance
- Gastrointestinal endoscopy + biopsy: The gold standard for confirming IBD, requiring histological scoring by a pathologist according to WSAVA standards
Differentiating IBD from Small Cell Lymphoma
Distinguishing feline IBD (particularly lymphocytic-plasmacytic enteritis) fromlow-grade alimentary lymphoma is one of the most challenging issues in veterinary practice. According to research in Veterinary Pathology (Moore et al., 2012):
- The clinical symptoms of both conditions are nearly identical
- Routine histological examination may sometimes fail to clearly differentiate them
- Immunohistochemistry (IHC) and lymphocyte clonality analysis (PARR/PCR)can improve diagnostic accuracy
- IBD may potentially progress to lymphoma, suggesting both conditions may represent different stages along the same disease spectrum
Important note: Even if diagnosed as small cell lymphoma, the prognosis is generally still good. According to research in the Journal of Veterinary Internal Medicine (Stein et al., 2010), cats with small cell lymphoma treated with Chlorambucil and Prednisolone had a median survival time exceeding 2 years.
Dietary Elimination Trials
Dietary trials are a key step in IBD management, as some cases diagnosed as IBD are actuallyFood-Responsive Enteropathy (FRE). According to ISFM guidelines:
- Trial duration: At least 4-6 weeks of strict dietary control
- Novel protein diet: Use a protein source the cat has never been exposed to (e.g., venison, rabbit)
- Hydrolyzed protein diet: Proteins broken down into small peptides to reduce immune response
- Strict compliance: No other foods, treats, or flavored medications during the trial period
- Approximately 50% of cats with chronic enteritis respond significantly to dietary modification
Medical Treatment
Immunomodulatory Therapy
- Prednisolone: First-line medication, typically started at a higher dose then gradually tapered. According to ACVIM recommendations, the starting dose is 1-2 mg/kg/day, adjusted after 4-6 weeks based on response
- Budesonide: A locally-acting corticosteroid with fewer systemic side effects, suitable for cases requiring long-term use
- Chlorambucil: A second-line medication for cases with poor response to corticosteroids or when dose reduction is needed
- Metronidazole: Has immunomodulatory and antimicrobial properties, can be used as adjunctive therapy
Supportive Care
- Vitamin B12 supplementation: B12 deficiency is very common in cats with IBD; supplementation can improve prognosis (Ruaux et al., 2005)
- Probiotics: Some studies suggest certain strains (such as Enterococcus faecium SF68) may be beneficial
- Antiemetics: Maropitant can help relieve vomiting symptoms
Prognosis
Most cats with IBD can achieve good control with appropriate treatment. Based on clinical experience and literature reviews, approximately 70-80% of cases respond well to dietary modification combined with medical therapy. However, IBD typically requireslifelong management, including long-term dietary control and regular follow-up. Relapses are common, and stress, dietary changes, or overly rapid medication tapering can trigger symptom recurrence. Regular monitoring of body weight, B12 levels, and clinical symptoms is essential for long-term management.
References
- Jergens, A.E. (2012). Feline idiopathic inflammatory bowel disease. Journal of Feline Medicine and Surgery, 14(7), 445-458.
- Moore, P.F. et al. (2012). Distinguishing IBD from intestinal lymphoma in cats. Veterinary Pathology, 49(3), 474-484.
- Stein, T.J. et al. (2010). Treatment of feline gastrointestinal small-cell lymphoma with chlorambucil and glucocorticoids. Journal of the American Animal Hospital Association, 46(6), 413-417.
- Ruaux, C.G. et al. (2005). Cobalamin and folate in cats with gastrointestinal disease. Journal of Veterinary Internal Medicine, 19(6), 816-823.
- WSAVA International Gastrointestinal Standardization Group. (2010). Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals.